December – post quiz

Episode 3 - December (post quiz)

Please complete the pre-masterclass test to view video.
Which of the following is considered standard first-line therapy in advanced EGFR-mutant NSCLC?(Required)
In patients who develop resistance to first-line osimertinib, what is the recommended next step?(Required)
Which of the following mutations is most commonly associated with resistance to EGFR TKIs?(Required)